| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |